Avian Coryza in Chickens: Clinical Signs, Diagnosis, and Management
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Avian coryza is an acute upper respiratory disease in chickens caused by Avibacterium paragallinarum, characterized by serous to mucopurulent nasal discharge, facial edema, conjunctivitis, and lacrimation.
- Diagnosis relies on isolation of A. paragallinarum on NAD-enriched media and molecular detection via PCR targeting the HMTp210 gene, which can differentiate pathogenic from nonpathogenic strains.
- Transmission occurs horizontally through direct contact, aerosols, and contaminated fomites, with a short incubation period of 1-3 days; recovered birds can become subclinical carriers.
- Control strategies integrate stringent biosecurity measures, all-in/all-out rearing, effective cleaning and disinfection, and vaccination with serovar-specific or multivalent bacterins.
- Antimicrobial resistance is a growing concern, necessitating susceptibility-guided therapy and exploration of alternative approaches such as probiotics and herbal extracts.
- Coinfection with other respiratory pathogens like Ornithobacterium rhinotracheale and Mycoplasma gallisepticum can significantly exacerbate clinical disease and mortality.
Introduction
Avian coryza, also termed infectious coryza, is an acute upper respiratory tract disease of chickens caused by the bacterium Avibacterium paragallinarum (formerly Haemophilus paragallinarum) [<a href="#ref-1">1</a>]. The disease is characterized by serous to mucopurulent nasal discharge, facial edema, conjunctivitis, and lacrimation [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. Although considered a disease of the upper respiratory tract, systemic complications such as septicemia have been reported, particularly in layers and breeders [<a href="#ref-3">3</a>]. The term avian coryn has been used in some diagnostic contexts to describe the clinical syndrome, though the accepted nomenclature remains infectious coryza [<a href="#ref-1">1</a>]. This article provides an exhaustive review of the etiology, epidemiology, clinical presentation, pathology, diagnostic modalities, therapeutic approaches, and control strategies for avian coryza in chickens.
Etiology and Pathogenesis
A. paragallinarum is a Gram-negative, pleomorphic, nonmotile, non-spore-forming coccobacillus that requires nicotinamide adenine dinucleotide (NAD or V factor) for growth [<a href="#ref-1">1</a>]. The bacterium is classified into serovars based on the Page scheme (A, B, C) and further subdivided by the Kume scheme [<a href="#ref-1">1</a>, <a href="#ref-4">4</a>]. The hemagglutinin protein HMTp210 is a major immunogen and serotyping antigen; regions of this protein define serovar specificity [<a href="#ref-5">5</a>]. Molecular genotyping of the HMTp210 gene has been proposed as an alternative to classical serotyping [<a href="#ref-4">4</a>].
Pathogenesis begins with colonization of the upper respiratory mucosa, facilitated by fimbriae and capsular polysaccharides [<a href="#ref-6">6</a>]. Lipooligosaccharide (LOS) structures and capsular polysaccharide (CPS) biosynthetic loci have been characterized and are implicated in virulence and host immune evasion [<a href="#ref-6">6</a>]. Biofilm formation is also a recognized trait: genes involved in biofilm production have been identified through random transposon mutagenesis [<a href="#ref-7">7</a>]. Natural transformation competence has been demonstrated, indicating the potential for horizontal gene transfer [<a href="#ref-8">8</a>]. Outer membrane vesicles (OMVs) from A. paragallinarum can mediate horizontal transfer of antibiotic resistance genes.
A number of nonpathogenic isolates have been recovered from naive, healthy layer flocks in the United States [<a href="#ref-9">9</a>, <a href="#ref-10">10</a>]. These isolates lack certain virulence determinants and can provide protective immunity against challenge with pathogenic strains [<a href="#ref-11">11</a>]. The presence of nonpathogenic strains complicates both diagnosis and epidemiological interpretation [<a href="#ref-12">12</a>].
Epidemiology
Avian coryza occurs worldwide, with prevalence influenced by climate, management practices, and biosecurity [<a href="#ref-13">13</a>]. A meta-analysis of Chinese poultry populations covering 1993-2024 reported a pooled prevalence of 18-25% in commercial flocks, with higher rates in layers and during cooler seasons [<a href="#ref-13">13</a>]. In the United States, retrospective analysis of outbreaks in California from 2016-2022 identified multifocal introduction patterns associated with farm density and live-bird markets [<a href="#ref-14">14</a>]. Case-control surveys in Pennsylvania highlighted risk factors such as lack of all-in/all-out management and shared equipment [<a href="#ref-2">2</a>, <a href="#ref-15">15</a>].
Transmission occurs horizontally via direct contact, aerosolized droplets, and contaminated fomites [<a href="#ref-1">1</a>]. The incubation period ranges from 1 to 3 days [<a href="#ref-1">1</a>]. Recovered birds may become subclinical carriers [<a href="#ref-1">1</a>]. Coinfection with other respiratory pathogens such as Ornithobacterium rhinotracheale and Mycoplasma gallisepticum can exacerbate clinical disease [<a href="#ref-3">3</a>] (see Avian Mycoplasma Infections: Pathogenesis, Diagnosis, and Vaccination Strategies in Poultry and Avian Bacterial Infections in Poultry: Comprehensive Review of Common Pathogens, Clinical Signs, and Diagnostic Approaches). Reports from Ethiopia [<a href="#ref-16">16</a>], Iran [<a href="#ref-17">17</a>], Poland [<a href="#ref-3">3</a>], and Argentina [<a href="#ref-18">18</a>] demonstrate the global distribution and genetic diversity of circulating strains.
Clinical Signs
Clinical signs of avian coryza are predominantly upper respiratory [<a href="#ref-1">1</a>]. The hallmark findings include serous to mucopurulent nasal discharge, sneezing, facial swelling (edema of the infraorbital sinuses), conjunctivitis, and lacrimation [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. In laying hens, a marked reduction in egg production (10-40%) is common [<a href="#ref-1">1</a>, <a href="#ref-19">19</a>]. Feed and water intake are reduced, leading to weight loss [<a href="#ref-1">1</a>]. Morbidity is high (up to 100%), but mortality is usually low unless exacerbated by concurrent infections or poor environmental conditions [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>].
Acute cases present with severe facial edema and purulent ocular discharge, while subacute forms may show only mild nasal exudate [<a href="#ref-1">1</a>]. The clinical course is typically 2-3 weeks in uncomplicated cases [<a href="#ref-1">1</a>]. Avian coryn syndrome may be used descriptively for cases that mimic infectious coryza but lack laboratory confirmation; however, definitive diagnosis requires pathogen isolation or molecular detection [<a href="#ref-1">1</a>, <a href="#ref-12">12</a>].
Pathology
Gross pathological findings include catarrhal to purulent exudate in the nasal passages, infraorbital sinuses, and trachea [<a href="#ref-1">1</a>]. In some cases, airsacculitis and pneumonia are observed, particularly when secondary pathogens are involved [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>]. Fibrinous peritonitis and endocarditis have been reported in layers and breeders coinfected with O. rhinotracheale [<a href="#ref-3">3</a>].
Histologically, the nasal mucosa shows acute inflammation with heterophil infiltration, congestion, edema, and epithelial desquamation [<a href="#ref-1">1</a>]. Hyperplasia of mucous glands and goblet cells is common [<a href="#ref-1">1</a>]. In chronic cases, lymphoplasmacytic infiltrates may predominate [<a href="#ref-1">1</a>].
Diagnosis
Sample Collection and Culture
Isolation of A. paragallinarum requires selective media because of its fastidious nature [<a href="#ref-20">20</a>]. Enriched media supplemented with NAD are essential [<a href="#ref-1">1</a>]. Novel selective agar formulations have been developed to improve recovery from clinical samples containing contaminating flora [<a href="#ref-20">20</a>]. Colonies appear as dewdrop-like after 24-48 hours of incubation in 5-10% CO2.
Molecular Detection
PCR assays targeting the HMTp210 gene are widely used for species confirmation [<a href="#ref-1">1</a>]. A validated multiplex PCR can differentiate pathogenic from nonpathogenic A. paragallinarum based on the presence or absence of virulence-associated determinants [<a href="#ref-12">12</a>]. This differentiation is critical because nonpathogenic strains can produce false-positive culture results [<a href="#ref-12">12</a>]. Additionally, PCR-based molecular serotyping targeting variable regions of HMTp210 has been developed as an alternative to classical serotyping [<a href="#ref-4">4</a>].
Genotyping and Epidemiology
A genome-guided multilocus sequence typing (MLST) scheme has been established, providing higher discriminatory power than traditional methods [<a href="#ref-21">21</a>]. Whole-genome sequencing and comparative genomics have revealed strain diversity, antimicrobial resistance genes, and serovar distribution [<a href="#ref-17">17</a>, <a href="#ref-22">22</a>, <a href="#ref-23">23</a>, <a href="#ref-24">24</a>]. Such genomic tools are increasingly used for outbreak tracing and surveillance.
Differential Diagnosis
Avian coryza must be differentiated from other respiratory diseases including avian influenza, Newcastle disease, infectious laryngotracheitis, fowl cholera, mycoplasmosis, and aspergillosis [<a href="#ref-1">1</a>] (refer to Infectious Coryza in Poultry and Ducks: Etiology, Clinical Signs in Chickens, Differential Diagnosis from Avian Influenza, and Prevention Strategies and Fowl Cholera in Chickens: Etiology, Clinical Signs, Diagnosis, and Control). A summary of key differentiating features is provided in Table 1.
Table 1. Differential diagnosis of avian coryza in chickens
| Disease | Etiologic Agent | Key Differentiating Signs |
|---|---|---|
| Avian coryza (infectious coryza) | Avibacterium paragallinarum | Facial edema, nasal discharge, conjunctivitis without severe tracheal hemorrhage |
| Avian influenza | Influenza A virus | Systemic signs, cyanosis, edema of comb and wattles, high mortality in HPAI |
| Newcastle disease | Avian orthoavulavirus 1 | Respiratory, nervous signs, tracheal rings hemorrhages |
| Infectious laryngotracheitis | Gallid alphaherpesvirus 1 | Severe dyspnea, bloody tracheal exudate |
| Fowl cholera | Pasteurella multocida | Septicemia, fibrinous pericarditis, hepatic necrosis |
A diagnostic workflow integrating clinical presentation, culture, PCR, and genotyping is presented in Figure 1.
flowchart TD
A["Clinical signs: nasal discharge, facial edema, conjunctivitis"] --> B["Sample collection: nasal swabs, sinus exudate"]
B --> C["Direct PCR: HMTp210 gene detection"]
B --> D["Culture on selective NAD-enriched agar"]
C --> E{"Positive for A. paragallinarum?"}
D --> F["Colony morphology +/- biochemical tests"]
E --> G["Differentiating PCR: pathogenic vs nonpathogenic"]
F --> G
G --> H["Positive for pathogenic strain"]
G --> I["Positive for nonpathogenic strain"]
H --> J["Antimicrobial susceptibility testing (broth microdilution)"]
J --> K["Therapeutic intervention"]
I --> L["Evaluate other pathogens: consider coinfection"]
H --> M["MLST/genome sequencing for epidemiology"]Treatment
Antimicrobial Therapy
Treatment of avian coryza typically involves administration of antibiotics effective against A. paragallinarum [<a href="#ref-1">1</a>]. However, antimicrobial resistance is a growing concern [<a href="#ref-24">24</a>, <a href="#ref-25">25</a>]. A standardized broth microdilution method for susceptibility testing has been recommended to enable consistent resistance monitoring [<a href="#ref-25">25</a>]. Resistance to sulfonamides, tetracyclines, and macrolides has been documented in genomic analyses of Chinese isolates [<a href="#ref-24">24</a>]. Horizontal transfer of resistance genes via OMVs further complicates management.
Alternative Approaches
Probiotics combined with berry phenolic extracts have shown inhibitory activity against A. paragallinarum in vitro [<a href="#ref-26">26</a>]. Chinese herbal medicine extracts also demonstrate bacteriostatic effects [<a href="#ref-27">27</a>]. These alternatives may be useful for reducing antibiotic use. In addition, Enterococcus faecium has been shown to improve vaccine immunity against infectious coryza when used as a dietary supplement [<a href="#ref-28">28</a>].
Vaccination
Vaccination is a cornerstone of control. Both inactivated (bacterin) and live attenuated vaccines are available [<a href="#ref-18">18</a>, <a href="#ref-29">29</a>]. A live attenuated strain developed through marker-free genetic manipulation shows promise as a safe and immunogenic candidate [<a href="#ref-29">29</a>]. Vaccine efficacy can be affected by serovar mismatch: a study in Argentina demonstrated that vaccination with serovar A bacterins provided incomplete protection against a serovar B variant, highlighting the need for multivalent formulations [<a href="#ref-18">18</a>]. Polymeric nanocarrier-based adjuvants have been developed to enhance mucosal immunity following local administration of coryza vaccines [<a href="#ref-30">30</a>]. Probiotic immunomodulation also augments vaccine responses [<a href="#ref-28">28</a>].
Control and Prevention
Control relies on biosecurity, management, and vaccination [<a href="#ref-1">1</a>, <a href="#ref-15">15</a>]. All-in/all-out rearing, effective cleaning and disinfection, avoiding introduction of carrier birds, and controlling flock density are critical [<a href="#ref-1">1</a>, <a href="#ref-15">15</a>]. Quarantine of new stock and separation of age groups reduce transmission [<a href="#ref-1">1</a>]. In endemically affected areas, vaccination programs using serovar-specific or multivalent bacterins are recommended [<a href="#ref-1">1</a>, <a href="#ref-18">18</a>].
The recent discovery of nonpathogenic A. paragallinarum strains that induce protective immunity suggests potential for live carrier-based vaccines [<a href="#ref-11">11</a>]. However, the presence of such strains in naive flocks complicates serological and molecular diagnosis [<a href="#ref-10">10</a>, <a href="#ref-12">12</a>].
Conclusion
Avian coryza remains a significant respiratory disease of chickens worldwide, with substantial economic impact due to egg production losses and increased morbidity. Molecular diagnostic advances, including serotype-specific PCR and whole-genome MLST, have improved both detection and epidemiological tracking. Antimicrobial resistance necessitates susceptibility-guided therapy and exploration of non-antibiotic alternatives. Integrated control combining biosecurity, vaccination, and careful management is essential for flock health.
Related Clinical & Scientific Guides
- Duck Diseases: A Comprehensive Overview for Veterinary Practitioners
- Salmonella Dublin in Cattle: Emerging Pathogen, Diagnostic Challenges, and Public Health Impact
- Mycoplasma Infections in Poultry: Vaccination Strategies and Control Programs